is glp 1 oral safe GLP-1 Medication Helps Patients Maintain Weight Loss | Research Your guide to GLP-1 side

Clinical trials have shown that discontinuing treatment typically results in gradual weight regain and worsening glycemic control, underscoring that these are chronic disease management tools rather than short-term interventions

for example, phentermine helps suppress appetite, while Contrave and Qsymia affect appetite, cravings, or fullness in different ways

5 Two factors drive this gap: Early discontinuation: About 22 % of semaglutide users and 16% of tirzepatide users stopped treatment within the first year, and many more quit after the one-year mark

Coverage may be considered only if the medication receives FDA approval in the future